Nurturing your advancements in oncology
Building towards precision medicineA better understanding of molecular events underlying cancer progression drives advancements in oncology. Relevant biomarker detection is necessary to determine the optimal strategies in cancer prevention and care. However, identifying the right tools to make biomarker profiling effortless is challenging. Our comprehensive portfolio makes it easy for you to access valuable insights. From sample collection to data interpretation – we provide the most robust technologies and resources to help you detect, analyze and validate relevant biomarkers. We continuously strive to innovate and expand the range of solutions we offer, further paving the path to precision medicine.
Latest insights – new solutions, events and more
Want to learn more about our oncology portfolio?
Our Sample to Insight solutions make it easy to access valuable biomarker information.
Inspiration from the lab
Professor Sue Branford is Head of the Leukaemia Lab in the Department of Genetics and Molecular Pathology at SA Pathology. She is a National Health and Medical Research Council Research Fellow and leads the International Chronic Myeloid Leukaemia Genomics Alliance. Learn about her journey and outstanding accolades, and her contributions to fighting blood cancer.
In-focus – relevant biomarkers and molecular signatures
Testimonials from our global lab partners
Explore our Cancer Research Hub.
Accelerate your journey to insights and help conquer cancer.